<DOC>
	<DOCNO>NCT00756171</DOCNO>
	<brief_summary>38 patient pruritus due chronic cholestatic liver disease evaluate investigator initiate , multicenter , double-blind , placebo-controlled , 3-week study assess effect colesevelam pruritus . Colesevelam oral , non-absorbable bile-acid sequestrant much potent cholestyramine free adverse effect . It register lipid lowering agent . The intensity symptom score mean daily Visual Analogue Scales ( VAS ) . Fatigue , quality life cutaneous scratch lesion also evaluate use quantitative instrument .</brief_summary>
	<brief_title>Colesevelam Versus Placebo Cholestatic Pruritus</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Pruritus</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>patient pruritus result cholestatic disorder age 18 year informed consent use cholestyramine pregnancy inability understand speak Dutch language malignancy/life expectancy &lt; 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Cholestatic</keyword>
	<keyword>pruritus</keyword>
	<keyword>cause</keyword>
</DOC>